What is Velsipity (etrasimod) for?
Velsipity (etrasimod) is a prescription medicine. It’s used to treat moderately to severely active ulcerative colitis in adults.
Velsipity (etrasimod) comes as tablets in a 2 mg strength.
How does Velsipity (etrasimod) work?
Etrasimod works by interacting with specific targets in the body. These are called sphingosine 1-phosphate (S1P) receptors. These receptors help move lymphocytes, a type of white blood cell, around the body.
Etrasimod binds strongly to certain S1P receptors, like types 1, 4, and 5. This binding controls the exit of lymphocytes from lymph nodes into the bloodstream. It reduces the number of lymphocytes in the blood.
In ulcerative colitis (UC), Etrasimod’s exact mechanism is not fully known. But it’s thought to lower lymphocyte movement into the intestines. This may help reduce inflammation and symptoms of the disease.
Where has Velsipity (etrasimod) been approved?
Velsipity (etrasimod) is approved by the FDA in the USA.
What are the benefits of Velsipity (etrasimod)?
Velsipity’s main advantage is treating the root cause of autoimmune diseases, not just symptoms. It modulates the immune system, reducing inflammation and improving patients’ quality of life.
Is Velsipity (etrasimod) safe and effective?
Clinical trials show Velsipity is safe and effective for autoimmune diseases. Patients see significant symptom improvements, with many achieving remission. It’s also well-tolerated, with fewer side effects than traditional treatments.
When will Velsipity (etrasimod) be available?
Velsipity is in the final stages of clinical trials. It’s expected to get approval soon. Once approved, it will be a major breakthrough in treating autoimmune diseases, offering hope to many.
Conclusion
Velsipity (etrasimod) is a big step forward in treating autoimmune diseases. It offers a new hope for those struggling with these conditions. Keep an eye on updates and talk to your doctor about Velsipity.
Reviews
There are no reviews yet.